Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Oyesanmi, O.
* Articles by Field, H. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Oyesanmi, O.
* Articles by Field, H. L.
Related Collections
* Other Treatment
* Anticonvulsants
* Antidepressants
Psychosomatics 40:414-421, October 1999
© 1999 The Academy of Psychosomatic Medine

Hematologic Side Effects of Psychotropics

Olu Oyesanmi, M.D., Elisabeth J.S. Kunkel, M.D., Daniel A. Monti, M.D., and Howard L. Field, M.D.

Received October 9, 1998; revised January 4, 1999; accepted February 17, 1999. From the Department of Psychiatry and Human Behavior, Jefferson Medical College, Philadelphia, Pennsylvania. Address correspondence and reprint requests to Dr. Kunkel, Jefferson Medical College, 1020 Sansom Street, Thompson Bldg., Suite 1652, Philadelphia, PA 19107–5004.

Psychiatrists are often unaware of the potential hematologic complications of the psychotropics they prescribe. Although this review is not a hematologic text reference, relevant hematologic syndromes are described so that the consultation-liaison psychiatrist will be familiar with the usual signs, symptoms, and treatments of these syndromes. This article reviews the hematologic side effects of the commonly prescribed psychotropics, including antipsychotics, antidepressants, benzodiazepines, lithium, mood stabilizers (including some of the anticonvulsants), and the acetylcholinesterase inhibitors. Clinical signs and symptoms that should alert the physician to obtain a complete blood count are described.

Key Words: Side Effects, Hematologic • Psychotropics • Pharmacology




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
S. Ghaznavi, M. Nakic, P. Rao, J. Hu, J. A. Brewer, J. Hannestad, and Z. Bhagwagar
Rechallenging With Clozapine Following Neutropenia: Treatment Options for Refractory Schizophrenia
Am J Psychiatry, July 1, 2008; 165(7): 813 - 818.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
J. D. Evans and E. W. Evans
Review of eight restricted-access programs and potential implications for pharmacy
Am. J. Health Syst. Pharm., June 15, 2007; 64(12): 1302 - 1310.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1999 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org